[Process and outcome quality in giant cell tumor in relation to surgical management].
Giant-cell bone tumors display a locally aggressive growth pattern, frequently recur if no adjuvant treatment is given, and may potentially metastasize. By virtue of their biological behavior and typically juxta-articular localization, giant-cell bone tumors require specific surgical management. Thus, an intralesional tumor excision must be supplemented by adjuvant bone cementing, possibly combined with instillation of phenol or cryotherapy. These combined treatment modalities assure a high-quality procedure, defined as the actual way medical care is delivered, by promoting the quality of the outcome, defined as the effect of a medical procedure on the patient's state of health.
Pingsmann
A
A
Orthopädische Klinik und Poliklinik Universität, Gesamthochschule Essen.
Müller
R T
RT
D000328:Adult; D001843:Bone Cements; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D003131:Combined Modality Therapy; D003452:Cryosurgery; D005260:Female; D018212:Giant Cell Tumor of Bone / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008768:Methylmethacrylates; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging / Q000601:surgery; D016348:Osseointegration / Q000502:physiology; D019800:Phenol; D010636:Phenols / Q000008:administration & dosage; D011247:Pregnancy; D011785:Quality Assurance, Health Care; D011859:Radiography; D007507:Therapeutic Irrigation; D013977:Tibia / Q000000981:diagnostic imaging / Q000601:surgery*
D001843:Bone Cements; D008768:Methylmethacrylates; D010636:Phenols; D019800:Phenol